KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Investing Activities (2016 - 2026)

Gilead Sciences filings provide 17 years of Cash from Investing Activities readings, the most recent being -$1.8 billion for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 715.56% to -$1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.8 billion, a 38.97% decrease, with the full-year FY2025 number at -$4.8 billion, down 38.97% from a year prior.
  • Cash from Investing Activities hit -$1.8 billion in Q4 2025 for Gilead Sciences, down from -$427.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$225.0 million in Q4 2024 to a low of -$2.2 billion in Q1 2024.
  • Median Cash from Investing Activities over the past 5 years was -$530.0 million (2021), compared with a mean of -$805.2 million.
  • Biggest five-year swings in Cash from Investing Activities: soared 96.9% in 2021 and later crashed 715.56% in 2025.
  • Gilead Sciences' Cash from Investing Activities stood at -$278.0 million in 2021, then crashed by 34.89% to -$375.0 million in 2022, then crashed by 93.87% to -$727.0 million in 2023, then surged by 69.05% to -$225.0 million in 2024, then crashed by 715.56% to -$1.8 billion in 2025.
  • The last three reported values for Cash from Investing Activities were -$1.8 billion (Q4 2025), -$427.0 million (Q3 2025), and -$2.1 billion (Q2 2025) per Business Quant data.